Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Boston Mountain Biotech - aVenture Company Research

Boston Mountain Biotech

Boston Mountain Biotech

Boston Mountain Biotech, a US-based contract research organization, streamlines pharmaceutical manufacturing with its Lotus Technology, enhancing protein therapeutics, vaccines, and enzyme development.

Fayetteville, AR, US🇺🇸

Founded

Boston Mountain Biotech is a US-based contract research organization focused on pharmaceutical manufacturing. Utilizing its proprietary Lotus Technology, the company enhances the development and manufacturing of recombinant protein therapeutics, vaccines, and enzymes by reducing host cell protein load in downstream processing. Their services span from upstream cell line development to downstream protein purification.

Boston Mountain Biotech has made significant strides in the biotech industry by simplifying complex manufacturing processes, thereby improving efficiency and product quality. Their innovative approach has positioned them as a key player in pharmaceutical manufacturing, contributing to advancements in therapeutic and vaccine development.

Boston Mountain Biotech - Similar Companies

Rocky Mountain Biosystems

Brighton Biotech

Sunflower Therapeutics

sunflowertx.com

Boston Mountain Biotech - Quick Facts

Who are Boston Mountain Biotech's competitors?

Companies similar to Boston Mountain Biotech include Rocky Mountain Biosystems, Brighton Biotech, Sunflower Therapeutics and AutekBio.

When was Boston Mountain Biotech founded?

Boston Mountain Biotech was founded in 2011.

Where is Boston Mountain Biotech's headquarters located?

Boston Mountain Biotech's headquarters is located in Fayetteville, AR, US.

When was Boston Mountain Biotech's last funding round?

Boston Mountain Biotech's most recent funding round was for $269.8k (USD) in December 2015.

Boston Mountain Biotech - Classification

Industry: Professional Service Companies
Ownership: Private
Technology: Biotech

How much disclosed funding has Boston Mountain Biotech raised?

As of Dec 8, 2015, Boston Mountain Biotech has disclosed funding of $269.8k (USD). Undisclosed round amounts are excluded.

How many employees does Boston Mountain Biotech have?

Boston Mountain Biotech has 3 employees as of Feb 5, 2024.

Geographic Exposure

United States

Customer: Enterprise
Main Product: Manufacturing
Research

Tags: Consulting

NAICS: 540000Professional, Scientific, and Technical Services
541714Research and Development in Biotechnology (except Nanobiotechnology)
541000Professional, Scientific, and Technical Services
541700Scientific Research and Development Services
541710Research and Development in the Physical, Engineering, and Life Sciences
SIC: 8700Engineering, Accounting, Research, Management, And Related Services
8730Research, Development, And Testing Services
8731Commercial Physical and Biological Research

Show 4 more industry codes

NAICS: 620000Health Care and Social Assistance
SIC: 8000Health Services
8040Offices And Clinics Of Other Health Practitioners
8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified

AutekBio

Lariat Biosciences

August Bioservices

augustbio.com

Lotus BioScience Ventures

Boca Biolistics

bocabio.com

Lucaspye BIO

lucaspyebio.com

Boston Biopharma

BiotechInnova

biotechinnova.com

Protein Foundry

proteinfoundry.com

Midwest Bioprocessing Center

Great Lakes Biologics

Ventria Bioscience